We are live on ! Find out more
DRIOW

DarioHealth Corp. Warrant
DRIOW

Delisted

DRIOW was delisted on the 4th of March, 2021.

Back to rankings

1 hedge funds and large institutions have $42K invested in DarioHealth Corp. Warrant in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% less capital invested

Capital invested by funds: $110K → $42K (-$68K)

75% less funds holding

Funds holding: 4 → 1 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-3
Holders Change %
-75%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$144

Top Sellers

Rank Fund Capital Flow
1
ICM
Ionic Capital Management
New York
-$48K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
1
Bard Associates
Illinois
$42K – – –
ICM
2
Ionic Capital Management
New York
– -$48K -73,663 Closed
UBS Group
3
UBS Group
Switzerland
– +$144 +200 +100%

DRIOW Hedge Fund Activity: Q1 2017 in Review

1 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q1 2017, worth a combined $42K — down 62% from $110K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DRIOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $144. The largest seller was Ionic Capital Management, exiting entirely with an estimated $48K sold.

  • 1 institutional investor held DarioHealth Corp. Warrant (DRIOW) as of Q1 2017, down from 4 in Q4 2016.
  • Funds reported $42K of DarioHealth Corp. Warrant stock for Q1 2017, down 62% quarter-over-quarter.
  • 0 funds opened new DarioHealth Corp. Warrant positions in Q1 2017 and 1 closed out, a net change of -1 holder.
  • The largest DarioHealth Corp. Warrant buyer in Q1 2017 was UBS Group, an estimated $144 added.
  • The largest DarioHealth Corp. Warrant seller in Q1 2017 was Ionic Capital Management, an estimated $48K sold.

Based on aggregated 13F filings for Q1 2017.